## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%); PEG 1.61 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($470.95)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Lobbying Update: $60,000 of LOCKHEED MARTIN CORPORATION lobbying was just disclosed**
- Source: Quiver Quantitative | 20251227T001007 | Neutral | Relevance: 100%
- LOCKHEED MARTIN CORPORATION (LMT) recently disclosed $60,000 in lobbying expenditures for Q4 2025, covering issues like the National Defense Authorization Act and acquisition policy. This article also details congressional stock trading, insider trading activity, and hedge fund movements related to LMT, alongside recent analyst ratings and price targets for the stock.

**2. Lockheed Martin secures $92.8 million contract modification for AEGIS**
- Source: Investing.com | 20251229T222827 | Bullish | Relevance: 100%
- Lockheed Martin Rotary and Mission Systems has been awarded a $92.8 million contract modification by the U.S. Naval Sea Systems Command for AEGIS system sustainment. This cost-plus-incentive-fee modification supports AEGIS sustainment services for Australia, Japan, and Korea, with work to be completed by December 31, 2026. Japan receives the largest portion of the funds, followed by Korea and Australia.

**3. Lockheed Martin Stock (LMT) Opinions on Pentagon Contract Expansion**
- Source: Quiver Quantitative | 20251229T170759 | Somewhat-Bullish | Relevance: 100%
- Lockheed Martin (LMT) is experiencing mixed opinions following a $25 billion Pentagon contract expansion, generating positive social media buzz regarding growth potential due to increased demand for defense solutions. However, concerns about cash flow challenges projected for 2027 by some analysts are tempering long-term optimism with near-term pressure. Insider trading shows more sales than purchases, while institutional investors show a mixed sentiment of adding and decreasing positions.

**4. Lockheed Martin Stock (LMT) Today: Pentagon Contract Boosts, F‑35 Scrutiny, and Analyst Targets Ahead of Monday’s Open**
- Source: ts2.tech | 20251227T070758 | Somewhat-Bullish | Relevance: 98%
- Lockheed Martin (LMT) is experiencing a mixed sentiment with new Pentagon contract boosts for C-130J aircraft and a significant Space Development Agency award, reinforcing its backlog and cash flow. However, the company faces scrutiny over F-35 sustainment issues and analyst downgrades due to concerns about future cash flow and growth constraints. Investors are monitoring geopolitical headlines, program execution, and upcoming interest rate expectations ahead of the next market session and the Q1 earnings report.

**5. RTX Secures $104M ESSM Deal, Strengthens Global Missile Leadership**
- Source: The Globe and Mail | 20251229T140900 | Somewhat-Bullish | Relevance: 74%
- RTX Corporation's Raytheon segment secured a $104.1 million contract for technical and design agent engineering support for the Evolved SeaSparrow Missile (ESSM) and NATO SeaSparrow Missile Systems programs, with work set to complete by December 31, 2026. This deal, combining purchases for the U.S. Navy and other countries, underscores the global demand for RTX's combat-proven ESSM missile, a defense solution against high-speed anti-ship cruise missiles and other threats. The missile and missile defense systems market is projected to grow, benefiting RTX and other defense contractors like Northrop Grumman, Lockheed Martin, and Boeing.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $515 | $465 | +11% |
| 2025-12-16 | Morgan Stanley | $543 | $630 | -14% |
| 2025-12-12 | Citigroup | $505 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | down | Neutral |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-12-12 | Citigroup | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.61 elevated, pricing in significant growth expectations. Forward P/E 16.7x attractive for 31% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $114.1B |
| Beta | 0.24 |
| 52W Range | $410.11 - $516.00 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.61 |
| Forward P/E | 16.7 |
| Current P/E | 22.0 |
| YoY Growth | 31.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 0.9% (minimal 5-day change). Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.35), confirming momentum. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.94% (CS: 85) | Neutral |
| RSI_14 | 62.6 | Neutral |
| MACD Histogram | 2.35 | Bullish |
| vs SMA20 | 1.042x | Above |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 1.050x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $488.93
- **Stop Loss:** $470.95 (3.7% risk)
- **Target:** $506.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 76
- **Position Value:** $37,158.68
- **Portfolio %:** 37.16%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*